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Abstract
Background: Gonadal sex determination (GSD) in humans is a complex biological
process that takes place in early stages of embryonic development when the
bipotential gonadal primordium (BGP) differentiates towards testes or ovaries. This
decision is directed by one of two distinct pathways embedded in a GSD network
activated in a population of coelomic epithelial cells, the Sertoli progenitor cells (SPC)
and the granulosa progenitor cells (GPC). In males, the pathway is activated when the
Sex-Determining Region Y (SRY) gene starts to be expressed, whereas in females the
WNT4/β-catenin pathway promotes the differentiation of the GPCs towards ovaries.
The interactions and dynamics of the elements that constitute the GSD network are
poorly understood, thus our group is interested in inferring the general architecture of
this network as well as modeling the dynamic behavior of a set of genes associated to
this process under wild-type and mutant conditions.
Methods: We reconstructed the regulatory network of GSD with a set of genes
directly associated with the process of differentiation from SPC and GPC towards Sertoli
and granulosa cells, respectively. These genes are experimentally well-characterized
and the effects of their deficiency have been clinically reported. We modeled this GSD
network as a synchronous Boolean network model (BNM) and characterized its
attractors under wild-type and mutant conditions.
Results: Three attractors with a clear biological meaning were found; one of them
corresponding to the currently known gene expression pattern of Sertoli cells, the
second correlating to the granulosa cells and, the third resembling a disgenetic gonad.
Conclusions: The BNM of GSD that we present summarizes the experimental data on
the pathways for Sertoli and granulosa establishment and sheds light on the overall
behavior of a population of cells that differentiate within the developing gonad. With
this model we propose a set of regulatory interactions needed to activate either the SRY
or the WNT4/β-catenin pathway as well as their downstream targets, which are critical
for further sex differentiation. In addition, we observed a pattern of altered regulatory
interactions and their dynamics that lead to some disorders of sex development (DSD).
Keywords: Sex determination, Gonadal sex determination, Boolean model, Gene
regulatory network
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Background
Sex development is a complex biological process that occurs during the embryonic and
fetal stages of an individual. For a better understanding sex development is divided
into three consecutive steps: 1) chromosomal sex determination (CSD); 2) gonadal
sex determination (GSD); and 3) phenotypic sex differentiation (PSD). CSD is estab-
lished at conception when the complement of sex chromosomes, XX or XY, is received.
GSD, which is the process that we analyze in this study, refers to the set of genes
and their regulatory interactions that trigger the development toward testes or ovaries,
underlined by a gene regulatory network [1–4]. Finally, PSD involves the development
of the female and male internal and external genitalia in response to the hormones
secreted by the ovaries and testes. Both male and female PSD occur in two tempo-
ral phases, the first occurs within the fetus after GSD and the second occurs during
puberty [5, 6].
GSD occurs within a heterogeneously composed structure called bipotential gonadal
primordium (BGP). This structure, located on the ventromedial surface of the
mesonephros [5–7], is critical for sex development since it can differentiate either as
testes or ovaries [8]. The BGP originates the actual gonad that is composed by a) the
germinal cells (GCs), b) the steroidogenic somatic cells, such as the theca cells in ovary
and the Leydig cells in testis that produce stradiol and testosterone, respectively; and
c) the support somatic cells, including granulosa cells in ovary and Sertoli cells in
testis.
Sertoli and granulosa cells originate from a common population of coelomic epithelial
cells corresponding to the Sertoli progenitor cells (SPC) or granulosa progenitor cells
(GPC) that migrate towards the BGP [9, 10]. In males, the SPCs start to differentiate
toward Sertoli cells after 44 days of development (Carnegie-Stage 18). The mechanism
involves activation of the expression of the Sex-determining Region Y gene (SRY ) that
codifies the SRY transcription factor [9, 11]. SRY associates with other transcription fac-
tors (i.e., CBX2, SF1) to regulate expression of the SOX9 gene that positively regulates the
expression of genes associated to Sertoli cells (i.e., SOX9, FGF9, PGD2, DHH, AMH) [2].
In females, where SRY is absent, GSD initiates after 49 days of development (Carnegie-
Stage 20). In this case, the GPCs of coelomic origin differentiate towards granulosa cells
by the action of a distinct gene regulatory pathway. Most likely, an increased amount of
the transcription factor β-catenin up-regulates a set of downstream genes associated to
granulosa, such as FOXL2 and RSPO1 [2, 12, 13]. Thus, the mechanism underlying GSD
involves a common population of undifferentiated cells with the potential to diverge into
two cell fates. The male pathway leads towards Sertoli cell fate determination and dif-
ferentiation, whereas the female pathway leads to granulosa cell fate determination and
differentiation.
Once differentiated, the Sertoli cells act as organizing centers, enclosing GCs to form
testicular cords and secreting factors such as DHH and PDGF, which are essential for
development of the fetal population of Leydig cells [14]. Granulosa cells are the female
equivalent of the Sertoli cells, as they enclose GCs and secrete factors necessary for
oocyte growth and maturation. The regulatory network controlling GSD and differentia-
tion toward Sertoli or granulosa cell consists, in a broad sense, of multiple target genes,
different types of RNAs, transcription factors, nuclear receptors and signaling molecules.
These elements are present in undifferentiated cells and interact in a concerted way either
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activating or repressing target genes at the time of GSD to balance the fate toward Sertoli
or granulosa cells [15–17].
The total number of genes implicated in the regulatory network of GSD of humans
and mammals remains elusive, as well as their complete regulatory interactions and their
effects on the process of Sertoli or granulosa cells differentiation. However, it is well
known that mutations in their components underlay the so-called disorders of sex devel-
opment (DSD), a series of genetic conditions characterized by anomalies in gonads as
well as in internal and external genitalia. The incidence of DSDs, as estimated by the
The Lawson Wilkins Pediatric Endocrine Society (LWPES) and the European Society for
Pediatric Endocrinology (ESPE), is 1 in 4,500 births [18] and can be attributed to muta-
tions in various genes of the GSD network. For example, mutations in CBX2, GATA4 and
WT1 genes result in a wide range of phenotypic alterations characterized by ambiguous
or female external genitalia with the presence or absence of Mullerian structures in 46,XY
DSDs patients [19]. In contrast, 46,XX DSDs cause masculinization of the female fetus
(normal males with no ovarian tissue) [20]. In other cases 46,XX DSD patients have a
female phenotype but fail to develop ovaries, presenting instead a “streak gonad”? (streaks
of connective fibrous tissue) [21].
Boolean network models (BNM) are formal tools for analyzing the structure and
dynamic behavior of genetic regulatory networks. BNM are best suited for describing
poorly-characterized systems with no or few kinetic details, such as the GSD network.
These models represent molecular entities (genes, transcription factors and RNAs) as
nodes interacting among them within a network. Each node can have only two qualitative
states: 0 (OFF) and 1 (ON). The OFF state is equivalent to a below-threshold concen-
tration or activity, which is insufficient to initiate the intended process or regulation,
while the ON state is equivalent to an above-threshold concentration or activity [22]. The
ON/OFF state of a node within the network is determined by a Boolean function that
encompasses the known regulatory elements of the target node (transcription factors,
nuclear receptors, signaling molecules). The state of these regulatory elements is updated
over consecutive time steps of a simulation until the system converges to either a steady
state or a cycle. BNMs describe the dynamic state of the nodes in a network by updating
the state of the nodes according with the set of regulatory functions [23]. BNMs have been
implemented for the analysis of developmental programs such as flower morphogenesis
in A. thaliana [24], early cardiac development in mice [25], and expression pattern of the
segment polarity genes in Drosophila [26] to name a few.
Despite the relatively high incidence of DSDs, their molecular basis at the level of the
regulatory network remain poorly understood. Thus, we are interested in constructing
a BNM of the process of gonadal sex determination with an emphasis on the regulatory
elements that are present at early stages of development and control the differentiation of
SCP and GCP towards Sertoli and granulosa cells, respectively, allowing us to analyze the
origin of some DSDs. For in-depth reviews about the genes involved in GSD and DSDs
see: [18, 19, 27, 28], as well as the list of genes and interactions in the Additional file 1 of
the supplementary information.
In this study we present a BNM that describes the dynamics of the GSD regulatory
network starting from the UGR until Sertoli/granulosa cells differentiation. The pro-
posed regulatory network incorporates a large amount of published information related
to functional interactions among the genes involved in this process, while the BNM of
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GSD describes the dynamics of the elements contained within the network under wild-
type and mutant conditions. With the current model we explore a formal description of
the functional relationships among the genes and gene products associated to GSD, and
generate some predictions about the expected regulatory behavior under wild-type or
altered conditions within elements of the UGR and elements of the bipotential gonadal
primordium such as CBX2, GATA4, and WT1. Additional predictions are indicated in
the female pathway where the transcription factor β-catenin seems to play an impor-
tant role in the activation of female-specific genes (for example, WNT4, RSPO1, and
FOXL2).
Methods
The network of gonadal sex determination
To construct the network we selected a set of genes with well-known clinical and
experimental data demonstrating their association to GSD under wild-type and mutant
conditions. The genes, depicted in a regulatory diagram (Fig. 1), include: CBX2, NR5A1,
GATA4, WT1pKTS, WT1mKTS, NR0B1, SRY, SOX9, FGF9, PGD2, DHH, AMH, DKK1,
DMRT1, CTNNB1, WNT4, FOXL2, RSPO1, and a special node called UGR. The inter-
actions among these nodes are denoted by edges. We distinguish positive interactions
(activation) by connecting two nodes with an arrow-head line. Negative interactions
(inhibition) are denoted by connecting two nodes with a bar-head line.
The regulatory interactions among nodes were inferred, with emphasis in humans,
from: (1) clinical studies of patients with DSDs, which carried mutations on sex deter-
mining genes; (2) genetic expression patterns associated to GSD (between 5th and 8th
weeks of embryonic development); and (3) molecular evidence of interactions at the
level of transcriptional regulation of target genes (i.e., up or down regulation of a tar-
get gene by means of protein-DNA interactions under wild type, mutated or transgenic
constructs). Experimental evidence on mice was integrated into the network when neces-
sary, especially in the female pathway where human information is lacking. References to
clinical and experimental data can be found in the Additional file 1 of the Supplementary
Information.
The network includes the special UGR node, representing the urogenital ridge, an
embryonic structure precursor of the nephrogenic cord and gonads. The UGR node
encompasses the following genes: LHX1, LHX9, EMX2, PAX2 and, PAX8. Although
expression of these genes is essential for growth and maintenance of the UGR, little
evidence was found in human, as well as in mouse, about their specific regulatory inter-
actions, thus these genes were grouped within the UGR node, since mutations in any of
these genes impair subsequent gonadal development [29–31].
The pathway towards pre-Sertoli or pre-granulosa cells is shown in Fig. 1. The blue
nodes correspond to Sertoli cell fate determination pathway and include: SRY, SOX9,
FGF9, PGD2, DHH, AMH,DKK1 andDMRT1 nodes, whereas the pink nodes correspond
to granulosa cell fate determination pathway including: CTNNB1, WNT4, FOXL2 and
RSPO1. Notice that the granulosa cell fate determination was complemented with mice
information. For example, we considered the canonical Wnt4/β-catenin pathway as a key
regulatory element of female nodes within the network since relative expression of Fst,
Gng13, Foxl2, Irx3 and, Sp5 has been shown to be down-regulated when β-catenin is lost
in female mice in early stages of ovarian development [32].
Ríos et al. Theoretical Biology andMedical Modelling  (2015) 12:26 Page 5 of 18
Fig. 1 Network of Gonadal Sex Determination leading to Sertoli or granulosa cell fate commitment and
differentiation. The network was inferred from reviewed experimental evidence of genes associated within
the process and structured according to developmental stages in: urogenital ridge (UGR node), bipotential
gonadal primordium (yellow nodes), male pathway of sex determination (blue nodes), female pathway of sex
determination (pink nodes). Nodes represent genes; arrow lines denote activation; bar head lines indicate
inhibition; black, blue and, pink solid lines represent validated interactions in human; green solid lines
represent interactions validated in mouse; punctuated lines in orange represent model predictions
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The network as a Booleanmodel
The process of GSD is poorly characterized at the quantitative level, i.e., kinetic informa-
tion regarding the interactions of the elements of this regulatory network is still lacking,
therefore the implementation of the GSD network as a continuous model is, at this
moment, out of reach. Given this, we decided to model the network as a discrete dynami-
cal system so as to describe the qualitative observations that are experimentally reported.
Specifically, we used a Boolean approach where every node might have one of two pos-
sible states; 1 (ON) or 0 (OFF), indicating that a given node within the network model is
active or inactive, respectively.
To determine the activation state of each node in the GSD model we translated the
experimental regulatory interactions into a set of Boolean functions with the use of the
logical operators AND, OR and NOT (Table 1). The logical operator AND is used if two
nodes named A and B are required to activate a third node named C. The logical operator
OR is used if two nodes named A or B can activate, by its own, node C. The logical oper-
ator NOT is used if node A is an inhibitor of node B. Thus, the state of a given node over
time is determined by the activation state of its regulators. We integrated to the model
additional regulatory interactions not reported by observational or experimental studies
(Table 2). These interactions were inferred from analysis of the dynamics of the Boolean
model and might be considered as model predictions that deserve further experimen-
tation to be validated. Interactions of model predictions are shown in Fig. 1 as orange
dashed lines.
We performed an initial exhaustive evaluation of the dynamic behavior of the wild
type model, simulating all possible initial activation states. Three fixed-point attractors
were obtained, and we performed a search focused in finding the state transitions cor-
responding to both male and female pathways. To recover the wild type “male pathway”,
we initiated the simulations with the UGR node in ON. In contrast, to created a wild
type “female pathway”, without the SRY node, we set the UGR andWNT4 nodes as active
Table 1 Set of functions for the Boolean model of gonadal sex determination
UGR, UGR & ! (NR5A1 | WNT4)
CBX2, UGR & ! (NR0B1 & WNT4 & CTNNB1)
GATA4, (UGR | WNT4 | NR5A1 | SRY)
WT1mKTS, (UGR | GATA4)
WT1pKTS, (UGR | GATA4) & ! (WNT4 & CTNNB1)
NR5A1, (UGR | CBX2 | WT1mKTS | GATA4) & ! (NR0B1 & WNT4)
NR0B1, (WT1mKTS | (WNT4 & CTNNB1)) & ! (NR5A1 & SOX9)
SRY, ((NR5A1 & WT1mKTS & CBX2) | (GATA4 & WT1pKTS & CBX2 & NR5A1) | (SOX9 | SRY)) & ! (CTNNB1)
SOX9, ((SOX9 & FGF9) | (SRY | PGD2) | (SRY & CBX2) | (GATA4 & NR5A1 & SRY)) & ! (WNT4 | CTNNB1 | FOXL2)
FGF9, SOX9 & ! WNT4
PGD2, SOX9
DMRT1, (SRY | SOX9) & ! (FOXL2)
DHH, SOX9
DKK1, (SRY | SOX9)
AMH, ((SOX9 & GATA4 & NR5A1) | (SOX9 & NR5A1 & GATA4 & WT1mKTS)) & ! (NR0B1 & CTNNB1)
WNT4, (GATA4 | (CTNNB1 | RSPO1 | NR0B1)) & ! (FGF9 | DKK1)
RSPO1, (WNT4 | CTNNB1) & ! (DKK1)
FOXL2, (WNT4 & CTNNB1) & ! (DMRT1 | SOX9)
CTNNB1, (WNT4 | RSPO1) & ! (SRY | (SOX9 & AMH))
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Table 2 Set of regulatory interactions inferred from analysis of the dynamics of the Boolean model,
colored in orange, that deserve further experimentation to be validated
UGR, UGR & ! (NR5A1 | WNT4)
CBX2, UGR & ! (NR0B1 &WNT4 & CTNNB1)
GATA4, (UGR | WNT4 | NR5A1 | SRY)
WT1mKTS, (UGR | GATA4)
WT1pKTS, (UGR | GATA4) & ! (WNT4 & CTNNB1)
NR5A1, (UGR | CBX2 | WT1mKTS | GATA4) & ! (NR0B1 & WNT4)
NR0B1, (WT1mKTS | (WNT4 & CTNNB1)) & ! (NR5A1 & SOX9)
SRY, ((NR5A1 & WT1mKTS & CBX2) | (GATA4 & WT1pKTS & CBX2 & NR5A1) | (SOX9 | SRY)) & ! (CTNNB1)
SOX9, ((SOX9 & FGF9) | (SRY | PGD2) | (SRY & CBX2) | (GATA4 & NR5A1 & SRY)) & ! (WNT4 | CTNNB1 | FOXL2)
FGF9, SOX9 & ! WNT4
PGD2, SOX9
DMRT1, (SRY | SOX9) & ! (FOXL2)
DHH, SOX9
DKK1, (SRY | SOX9)
AMH, ((SOX9 & GATA4 & NR5A1) | (SOX9 & NR5A1 & GATA4 & WT1mKTS)) & ! (NR0B1 & CTNNB1)
WNT4, (GATA4 | (CTNNB1 | RSPO1 | NR0B1)) & ! (FGF9 | DKK1)
RSPO1, (WNT4 | CTNNB1) & ! (DKK1)
FOXL2, (WNT4 & CTNNB1) & ! (DMRT1 | SOX9)
CTNNB1, (WNT4 | RSPO1) & ! (SRY | (SOX9 & AMH))
at the beginning of simulations. Besides the wild type model, we simulated all possible
loss and gain of function of single mutants, so as to describe alterations in activation
states that might be interpreted as alterations in gene expression. Loss and gain of func-
tion single mutants were simulated by fixing the relevant node to 0 or 1, respectively. All
simulations were carried out under the synchronous updating scheme with the use of
BoolNet [33].
Testing properties of the Booleanmodel: random networks and robustness of attractors
We performed tests by creating random networks in order to analyze the frequency of
appearance of point attractors identical to those of the wild type model (Fig. 2). The tests
consisted in the construction of 1000 random networks with 19 nodes each one. The
number of inputs for each node in the random networks was the same as in the original
model. We kept this configuration in order to be consistent with the network architecture
of the model. The wild type attractors shown in (Fig. 2) were compared by performing
three independent tests of 1000 random networks each one. Additionally, we tested the
Fig. 2 Fixed point attractors of the Boolean model of gonadal sex determination. The attractors were
obtained by simulating all possible (219) initial activation states. The attractor with the largest basin of
attraction (50.95%) can be interpreted as the gene expression profile observed in the somatic pre-Granulosa
cells. The attractor with the second-largest basin (48.91%) can be interpreted as the gene expression profile
observed in the somatic pre-Sertoli cells. The model also presents a third attractor with a small basin covering
only 0.14% of the state space interpreted as a null attractor due to a UGR node set to zero
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robustness of the attractors of the BNMwith a set of 1000 perturbed copies of the network
by using the testNetworkProperties function of BoolNet [33]. This test gives the percent-
age of the original attractors shown in Fig. 2 recovered after 1000 copies of the Boolean
model functions randomly perturbed.
Results
The network of gonadal sex determination
The network was constructed with 19 nodes and 78 regulatory interactions: 42 of these
interactions have been reported in humans; 12 in mice and 24 were predicted from
analysis of transition states of the simulated Boolean model. The network is directed
towards the male pathway if the SRY node is active. SRY leads to activation of SOX9,
which in turn activates FGF9, PGD2, DMRT1, DHH, DKK1, and AMH nodes. At the
same time, the female pathway is repressed by inactivating CTNNB1 and FOXL2 nodes
(Fig. 1). On the contrary, the network is directed towards the female pathway in absence
of SRY and when theWNT4, CTNNB1, RSPO1 and, FOXL2 nodes are active. In this case,
the male pathway is repressed by CTNNB1 and FOXL2 mediated inactivation of SOX9,
DMRT1 and AMH (Fig. 1).
Predictions of the Boolean model
The current model contains 24 interactions inferred from dynamic modeling, these are
predominantly related to the UGR node and the genes expressed in the bipotential
gonad. Model predictions were drawn as orange dashed lines within the following nodes:
UGR, CBX2, GATA, WT1mKTS, WT1pKTS, NR0B1, SRY, DMRT1, DKK1, WNT4 and
CTNNB1 (Fig. 1). The model predicts that the activity of UGR depends of an activation
self-loop and functions as an input to activate CBX2, GATA4, Wt1mKTS, WT1pKTS,
and NR5A1 (Table 2). The scarcity of information regarding UGR function and mainte-
nance clearly indicates that more experimental studies are necessary to understand the
mechanisms of gene expression control in the BGP especially forCBX2,GATA4 andWT1.
Dynamic behavior of the gonadal sex determination Boolean network model
The dynamic behavior of the GSD BNM was exhaustively analyzed by starting the
dynamical simulations of the system from all possible 219 = 524288 initial states. After
simulations, three fixed-point attractors where obtained (Fig. 2). The first of these attrac-
tors can be interpreted as the gene expression profile observed in Sertoli cells, the second
can be interpreted as the gene expression profile observed in granulosa cells, and the third
attractor, with a very small basin of attraction, might represent a disgenetic gonad without
Sertoli or granulosa activity.
After the initial exhaustive search of the GSD attractors, we performed a search focused
in finding the state transitions of both male and female pathways. In the case of 46,XY
simulations, the UGR node was set to ON in the initial condition (Time step 0) to transit
toward the BPG and then turning ON the SRY node leading toward the Sertoli cell attrac-
tor. Since 46,XX wild type females do not have SRY gene, we searched from all possible
initial states the activation patterns that had UGR and female nodes as initial condition.
From this search we found that UGR + WNT4 were the initial conditions (Time-step 0)
to transit from the BPG toward the granulosa attractor. Thus in male and female simula-
tions we started with an active UGR node as the initial condition, followed by activation of
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the nodes representing the BPG (CBX2, GATA4, WT1mKTS, WT1pKTS, and NR5A1).
The NR0B1, WNT4 and RSPO1 nodes were subsequently activated, in agreement with
the reported gene expression patterns, showing that these genes are co-expressed in
both male and female embryos during the stage of BPG and previous to GSD (Fig. 3a
and b) [7, 34].
If the simulation transited toward the Sertoli attractor, then the NR0B1, WNT4 and
RSPO1 nodes were inactivated by NR5A1, SRY, SOX9 and DKK1 nodes. In male the
expression of NROB1 is dosage sensitive, since duplication of this gene in 46,XY patients
produces a male-to-female sex reversal with streak gonads [35]. It is important to notice
that NR0B1 might play an important role in male after the time of GSD because NR0B1
knockout mice showed disorganized Sertoli, Leydig and germ cells due to defects in
testis cord formation [36]. Thus, it has been suggested that NR0B1 has a time frame of
expression [37] with reduced levels of the DAX1 protein during GSD. Since the BNM con-
siders active or inactive states, the NR0B1 node was inactive at the sixth time step, which
corresponds to the Sertoli attractor (Fig. 3a)
When the UGR + WNT4 nodes were set to ON, two fixed point attractors were
obtained: (1) the granulosa attractor and the (2) dysgenetic gonad attractor. Thus the
transition towards the granulosa attractor is characterized by the initial activation of the
UGR +WNT4 and BPG nodes, followed by activation of the NR0B1, RSPO1, FOXL2 and
CTNNB1. As we previously stated, β-catenin, plays a key role in up-regulation of pre-
granulosa genes in female mouse [32], this factor actively antagonizes SOX9 and AMH
expression, inactivating the pathway toward Sertoli cells (Fig. 3b) [38, 39]. The attrac-
tor with no activity reflects the importance of the UGR node within the network model
a
b
Fig. 3 State transitions leading to a fixed point attractor corresponding to pre-Sertoli or to pre-granulosa
cells. The state of the nodes over time was simulated starting from an activated UGR node (1). White and
black cells represent inactive or active nodes respectively. The fixed point attractor toward pre-Sertoli is given
by activation of SRY node (a). The point attractor is in agreement with experimental observations after six
time steps, whereas the fixed point attractor toward granulosa is given by absence of SRY and activated
UGR+WNT4 nodes (b). The point attractor is in agreement with experimental observations after three time
steps
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given that loss of function mutants of UGR components have an impaired subsequent
gonadal development, as observed in mouse. Therefore, the dysgenetic gonad attractor
(i.e., streaks of fibrous tissue instead of a gonad) might be interpreted as a condition
expected in some individuals when gonadal development fails, especially in the case of
LHX1, LHX9, EMX2, PAX2 and PAX8mutants.
In summary, state transitions in Fig. 3a and b qualitatively coincide with gene expres-
sion patterns observed during GSD [7, 34]. However, notice that the state transitions
and steady state attractors must be considered as snapshots of the gene expression pat-
tern between 41–52 days of development and do not represent the complete process of
gonadal development.
Modeling disorders of sex development
46,XX sex reversal
We simulated the DSD known as 46,XX sex reversal or testicular DSD, characterized
by an apparently normal development of male structures, including testes and male
internal/external genitalia [20, 40]. To simulate such a condition either the SRY node
or the SOX9 node were left permanently active (ON = 1) during the entire simulation
(Fig. 4a, b). The SRY node activates SOX9 in coordination with CBX2, GATA4, WT1
and NR5A1, SOX9 in turn inhibits the female pathway through CTNNB1 inactivation.
CTNNB1 is the node of the transcription factor β-catenin, a key regulatory element of
the female pathway. Our BNM generates in both simulations a Sertoli-like attractor that
presents activation of the FGF9, PGD2, DMRT1, DHH, DKK1 and AMH nodes. The sim-
ulation observed in Fig. 4a might be interpreted as the process underlying a 46,XX sex
a
b
Fig. 4 Modeling 46,XX sex reversal. The SRY node was kept as active (1) so as to simulate traslocation in a
46,XX background. SRY activates SOX9 in combination with CBX2, GATA4, WT1 and NR5A1. Then, SOX9
activates nodes associated with the male pathway (i.e., FGF9, PGD2, DHH, AMH). The fixed point attractor can
be interpreted as a 46,XX sex reversal after three time steps (a). The SOX9 node was set as active in order to
simulate a duplication in a 46,XX background (b). The resulted activation states were similar to the observed
in the male pathway. Thus, the fixed point attractor can be interpreted as a 46,XX sex reversal in absence of
SRY, as reported in clinical cases
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reversal when the SRY gene is translocated to one autosomic chromosome or to the X
chromosome, whereas the simulation in Fig. 4b might represent a 46,XX sex reversal due
SOX9 gene duplication.
46,XY (SRY-) sex reversal
SRY is considered the trigger of the male pathway and testis development [9]. This tran-
scription factor possesses a highly conserved domain called HMG box that binds to the
GAACAAAG DNA motif and bends the DNA molecule about 80 degrees. The loss of its
chromatin-remodeling activity [41] is considered to impair the three dimensional archi-
tecture of chromatin and compromises the proper interaction of SRYwith its target genes.
Mutation of the DNA binding region of SRY in 46,XY subjects has been associated with
female external genitalia, normal Mullerian ducts and streak gonads [42]. When we sim-
ulated the SRY loss of function, the female pathway was activated by the CTNNB1 node
and the male pathway blocked through a CTNNB1 and FOXL2- mediated SOX9 inhi-
bition. SRY is considered the trigger of testis development by expressing in the somatic
pre-Sertoli cells [9]. The mechanism suggested for normal function of this transcrip-
tion factor is a highly conserved domain within the protein, called High Mobility Group
(HMG box).
Concerning the model simulation in Fig. 5c, loss-of-function of SRY leads to inacti-
vation of the male and activation of the female pathway. To this respect, Hawkings and
colleagues [42] described five subjects with 46,XY karyotype associated with completely
female external genitalia, normal Mullerian ducts, and streak gonads. All the patients
showed mutations in the DNA binding region of the SRY protein [42]. Since model sim-
ulations agree with clinical observations of loss-of-function mutations in the HMG box
of SRY, we interpret this simulation as the possible gene expression dynamics in a 46,XY
(SRY-) individual during the time of GSD. In these subjects the female pathway would
become active by increasing amounts of β-catenin within the cell nucleus and active
repression of the male pathway by a B-catenin and FOXL2-mediated inhibition of SOX9.
Given this results we interpret that our simulations (Fig. 5c) resemble the early gene
expression dynamics in a 46,XY (SRY-) individuals.
Modeling other DSDs
Other relevant elements that have a common function in both male and female pathways
at the BPG and thorough the differentiation of testis and ovaries are the transcription
factors GATA4 and WT1. In the case of GATA4, it has been observed in mice that
GATA4 is expressed at E10.5 during formation of the UGR and its deficiency impairs
subsequent gonadal differentiation [43]. In the male pathway, GATA4 associates with
the -KTS isoform of WT1 protein for an optimal activation of the SRY gene [44]. Other
example of the GATA4 protein activity in the male pathway is its role in the activa-
tion of the AMH gene in association with SF1 and WT1-KTS transcription factors
[45, 46]. Simulation of GATA4 loss of function in the male pathway is given in Fig. 6
(notice the altered dynamics of activation patterns compared with the wild-type simula-
tion shown in Fig. 3a). WT1mKTS, WT1pKTS, NR5A1 and AMH nodes were inactive
in the attractor because the GATA4 node is their positive regulator. The SRY node
remained active due to an activation self-loop and additional interactions with NR5A1,
WT1mKTS, CBX2 and a possible feedback loop with SOX9, thus the altered activation
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Fig. 5 Modeling 46,XY sex reversal. The CBX2 node was inactivated in order to simulate a loss of function
mutation in a 46,XY background which resulted in a steady state attractor that showed activation of female
nodes (a). The NR0B1 node was set as active in order to simulate a duplication in a 46,XY background. The
activation states were altered and resulted in an steady state attractor with activated female nodes (b). The
SRY node was inactivated in order to simulate a loss of function mutation which resulted in a steady state
attractor that showed activation of female nodes (c)
Fig. 6 State transitions when the GATA4 node was inactive (0) in a 46,XY context. The GATA4 node was
inactivated in order to simulate a loss of function mutation in a 46,XY background which resulted in
inactivated AMH node although an attractor with activated male nodes was recovered
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state shown in Fig. 6 might be interpreted as the source of a DSD. To this respect, the
clinical spectrum of developmental anomalies due to GATA4 mutations in male patients
is variable. Patients might show bilateral dysgenetic testes containing Sertoli cells and
no visible Leydig cells and show male internal genitalia to normal-ambiguous external
genitalia [46].
On the other hand, WT1 has a key role in the development of kidney and gonads, its
expression is observed at the UGR and continues through the differentiation of testis
and ovaries interacting in both pathways of cell differentiation. Homozygous mutations
in mice are embryonic lethal and result in renal agenesis, as well as cardiac and gen-
ital tract abnormalities [29]. Since WT1 is an important element in early stages of
gonadal development we simulated the loss of function of WT1 in a 46,XY context
(Fig. 7), notice that the attractor has an activation pattern similar to the female path-
way. Importantly, mutations in this gene impair the development of male in a certain
degree; mutations in the intron 9 splice site of the WT1 gene affects the balance of
the +KTS/-KTS isoforms impairing the development of testis resulting in streak gonads
and ambiguous external genitalia [47]. In females the role of WT1 is less defined, how-
ever there is experimental evidence about its role in the positive regulation of the
NR0B1 gene by binding to two potential sites located at the 5 flanking region of the
gene [48].
We analyzed in addition the effect of loss-of-function mutations in the NR5A1 node.
Since the dynamics of the simulations of WT1 and NR5A1 were identical we show only
the attractor in Fig. 7.
Testing properties of the Booleanmodel: randomnetworks and robustness of the attractors
On average, the three independent tests of 1000 random networks generated 103,000
attractors each one. We found that none of the random networks recovered the set of
three point attractors of the wild typemodel shown in Fig. 2. This results indicate that the
attractors of our BNM could not be expected in a network made with random interac-
tions. Thus, the attractors in Fig. 2 can be considered as biologically meaningful and not
a statistical artifact.
Concerning the test of attractor robustness we observed that 95% of the perturbed
networks recovered less than 30% of the original attractors of our model. This means
that the model is relatively sensitive to perturbations in the functions of the model. The
reduced robustness can be due to the scarce redundancy in the model, given that we
opted by including a small number of regulatory molecules, so as to be close to a minimal
model. We expect that the introduction of more nodes and regulatory feedback circuits
would result in an increased robustness.
Fig. 7 Fixed point attractors when setting NR5A1 or WT1 inactive (0) in a 46,XY context
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Discussion
The classical observations of Alfred Jost (1947) that early castration in utero of rabbit
fetuses resulted in female internal and external genitalia (independent of their chro-
mosomal sex complement) lead to the hypothesis of a testis-determining factor (TDF).
According to this hypothesis the ovary was considered the default developmental state,
while testis represented an induced and active state that repressed female development.
Experimental evidence accumulated in the last 20 years have enriched our view of
sex determination where developmental programs toward testis or ovaries represent
two independent antagonistic regulatory pathways of high complexity intertwined in a
regulatory network: the GSD network.
The BNM used in this study, although discrete in its approach, can be considered as a
simplified version of a very dynamic and complex biological network that incorporates
the major regulatory elements of the GSD network. The GSD BNM summarizes in a
formal language the set of experimentally-confirmed interactions associated with the pro-
cess of GSD. Although the attractors obtained in our model cannot be interpreted as as
anatomical structures of high developmental complexity, they can be reliably seen as the
gene expression profiles expected during the process of determination and differentiation
of SPC and GPC towards Sertoli and granulosa cells respectively.
The network of gonadal sex determination
We inferred the regulatory network of human GSD andmodeled it as a BNM.With such a
model we were able to describe the molecular dynamics of the first stage in gonadal mor-
phogenesis, which is the cell fate determination and further differentiation of Sertoli and
granulosa cells. The network contains 19 nodes as well as their regulatory interactions, as
evidenced by published experimental and clinical data.
Recent studies regarding early gonadal differentiation suggest a highly complex biolog-
ical process regulated by many, probably hundreds, of genes. However, our BNM shows
that only a handful of them are sufficient to activate the male or female pathway, allowing
us to propose that the gonadal fate commitment and differentiation is a direct conse-
quence of activation and repression of a transcriptional program encoded as a regulatory
network. Although part of the information used to infer this regulatory network was taken
from experiments in mice, we consider that the model might be considered as a good
approximation to the corresponding regulatory network in humans.
The Booleanmodel of gonadal sex determination
The BNM describes the dynamics of 19 nodes associated with GSD between 41–52 days
of embryonic development. The results cannot be considered as final activation states
of the biological process, instead they should be considered as a snapshot in the pro-
cess of Sertoli and granulosa cell differentiation. At the quantitative level, GSD is poorly
understood given the lack of information about kinetic details of each regulatory ele-
ment, therefore it is difficult to establish a continuous model with differential equations
with the current available data. Despite the large amount of gene expression data, little
is known about the regulatory mechanisms leading to GSD under normal conditions, as
well as their downstream effects under mutant conditions. To shed light about the regula-
tory mechanisms we used a discrete modeling approach because most of the information
relies on qualitative descriptions.
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Model predictions and the role of the UGR and bipotential gonad genes in early gonadal
development
The UGR is a very important structure within the developing embryo since it is the com-
mon structure that leads to testis and ovaries. Notice that just a few regulatory elements
of the UGR have been studied. For example, Lhx1 expression has been reported in mice
and has a key role in the development of kidney, female reproductive tract and anterior
head [30]. Conditional knockout mice lack uterus, cervix and upper vagina [49]. Lhx9 has
a role in the activation of Nr5a1 gene, in synergy with Wt1 in mice. Other example is
given by PAX2 and PAX8 genes. In humans, these genes have a role in the activation of
the WT1 gene [29, 50] thus, we underline the need for additional studies regarding the
regulatory interactions that led to the establishment of the UGR and BPG primordium.
As we mentioned previously, the human female pathway is less characterized, and its
current cumulative knowledge is mainly based on mice findings. In this case, the GATA4-
FOG2 complex has an important function by activating the Fst, Wnt4, Sprr2d, Foxl2,
Gng13 genes [32]. It has been observed in female mice that loss of function of Gata4
impairs the expression of these genes and leads to the development of a male-specific
coelomic vessel [32]; therefore GATA4 can be considered as a key regulatory element in
the early stages of gonadal development toward ovaries.
The role of WNT4/β-catenin in the female pathway
Concerning the female pathway most of the inferred interactions derive from mice. To
this respect we notice the role of the WNT4 and βcatenin nodes in the regulation of
WNT4, RSPO1, and FOXL2. In the biological process we predict a key role of β-catenin
regulating the female pathway. The general mechanism of the canonical Wnt4/β-catenin
signaling pathway can be explained as follows: the pathway is initiated by expression of
the wingless-type MMTV integration site family, member 4 (WNT4). The product of this
gene is a ligand that binds to Frizzled (Fz) and LRP5/6 co-receptors at the plasma mem-
brane, disengaging β-catenin from the proteins of the “destruction complex”? (Axin and
APC). Then β-catenin translocate into the nucleus where associates with TCF7/LEF, this
protein contains an HMG box with capacity to recognize specific DNA sequences. The
β-catenin-TCF7/LEF complex activates target genes, whereas in absence of β-catenin
TCF7/LEF alone represses gene transcription [51, 52]. From the set of interactions
inferred from mice, that fitted perfectly in our model, we would expect that β-catenin
might have an important role regulating the expression of the FST, FOXL2 and IRX3 genes
in humans.
The BNMof GSD summarizes in a formal language the set of experimentally-confirmed
interactions associated with the process of GSD. The attractors of our model can be
interpreted as the gene expression profiles expected during the process of GSD and dif-
ferentiation of Sertoli or granulosa cell lineages. According to our simulations, the loss of
function of GATA4 results in inactivation of the AMH node in the attractor. This result
is particularly interesting given the existence of the persistent Müllerian duct syndrome
(PMDS), a relatively rare inherited defect in the sexual differentiation, characterized by
failure in the regression of the Müllerian ducts in males. Affected individuals present per-
sistent uterus and tubes due to a defect in the synthesis of the AMH hormone, which is
normally produced by the Sertoli cells. Mutations in the AMH gene have been reported
in these patients [20, 53], however the majority of PMDS remain without molecular
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diagnosis, therefore GATA4 mutations emerge, according to our model predictions, as a
potential PMSD causing gene.
Conclusions
We propose the present model as a starting point for future mathematical modeling
and integration of experimental research regarding sex development. The model can be
upgraded in several aspects for example, incorporating additional nodes and interactions,
as well as modeling more cell lineages of the gonad such as the Leydig or theca cells.
Finally the current BNM describes the dynamics of the GSD network under perturba-
tions. Importantly the analysis of these states can have potential implications in the study
of DSDs.
Additional file
Additional file 1: Supplementary information. (PDF 47 kb)
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LT and SF conceived the project; OR, LM and AR developed the BNM and performed the simulations; LT and LM
coordinated computational work; OR, LT, LM, AR and SF, analyzed the data.; SK and HM provided important contribution
for including nodes and interactions and for discussion; OR, SF, and LT, wrote the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
OR thanks the support from the program Doctorado en Ciencias Biológicas, UNAM, and the scholarship 173000 from
Consejo Nacional de Ciencia y Tecnología (CONACyT). This work was supported by grants from CONACYT 166012 to HM,
Universidad Nacional Autónoma de México PAPIIT IN200514 to LM, and Recursos Fiscales para la Investigación del
Instituto Nacional de Pediatría, proyecto 057/2014 to LT. Adhemar Liquitaya from CompBioLab IIB, UNAM, aid with the
test of random networks.
Author details
1Instituto Nacional de Pediatría, Laboratorio de Citogenética, Av. Insurgentes Sur 3700 C, 04530 México City, México.
2Programa de Doctorado en Ciencias Biológicas, UNAM, Mexico City, México. 3Instituto de Investigaciones Biomédicas,
UNAM, 04510 Mexico City, México. 4Programa de Doctorado en Ciencias Biomédicas, UNAM, Mexico City, México.
5Facultad de Medicina/Hospital General de Mexico, Mexico City, México. 6C3, Centro de Ciencias de la Complejidad,
UNAM, 04510 Mexico City, México.
Received: 21 August 2015 Accepted: 30 October 2015
References
1. De Santa Barbara P, Moniot B, Poulat F, Berta P. Expression and subcellular localization of SF-1, SOX9, WT1, and
AMH proteins during early human testicular development. Dev Dynam. 2000;217(3):293–8.
2. Eggers S, Sinclair A. Mammalian sex determination insights from humans and mice. Chromosome Res. 2012;20(1):
215–38.
3. White S, Sinclair A. The molecular basis of gonadal development and disorders of sex development In: Hutson JM,
Warne GL, Grover SR, editors. Disorders of sex development: An Integrated Approach to Management. Heidelberg:
Springer Berlin; 2012. p. 1–9.
4. She ZY, Yang WX. Molecular mechanisms involved in mammalian primary sex determination. J Mol Endocrinol.
2014;53(1):R21–37.
5. Sajjad Y. Development of the genital ducts and external genitalia in the early human embryo. J Obstet Gynaecol Re.
2010;36(5):929–37.
6. Hutson JM. Embryology of the human genital tract In: Hutson JM, Warne GL, Grover SR, editors. Disorders of sex
development: An Integrated Approach to Management. Heidelberg: Springer Berlin; 2012. p. 11–21.
7. Hanley NA, Hagan DM, Clement-Jones M, Ball SG, Strachan T, Salas-Cortes L, et al. SRY, SOX9, DAX1 expression
patterns during human sex determination and gonadal development. Mech Develop. 2000;91(1):403–7.
8. Kim Y, Capel B. Balancing the bipotential gonad between alternative organ fates: a new perspective on an old
problem. Dev Dynam. 2006;235(9):2292–300.
9. Albrecht KH, Eicher EM. Evidence that SRY is expressed in pre-Sertoli cells and Sertoli and granulosa cells have a
common precursor. Dev Biol. 2001;240(1):92–107.
10. Ungewitter EK, Yao HC. How to make a gonad: cellular mechanisms governing formation of the testes and ovaries.
Sex Dev. 20013;7(1-3):7–20.
Ríos et al. Theoretical Biology andMedical Modelling  (2015) 12:26 Page 17 of 18
11. Kashimada K, Koopman P. SRY: the master switch in mammalian sex determination. Development. 2010;137(23):
3921–30.
12. Harikae K, Miura K, Kanai Y. Early gonadogenesis in mammals: significance of long and narrow gonadal structure.
Dev Dynam. 2013;242(4):330–8.
13. Sarraj MA, Drummond AE. Mammalian foetal ovarian development: consequences for health and disease.
Reproduction. 2012;143(2):151–63.
14. Svechnikov K, Landreh L, Weisser J, Izzo G, Colon E, Svechnikova I, et al. Origin development and regulation of
human Leydig cells. Horm Res Paediatr. 2010;73(2):93–101.
15. Beverdam A, Koopman P. Expression profiling of purified mouse gonadal somatic cells during the critical time
window of sex determination reveals novel candidate genes for human sexual dysgenesis syndromes. Hum Mol
Genet. 2006;15(3):417–31.
16. Jameson SA, Natarajan A, Cool J, DeFalco T, Maatouk DM, Mork L, et al. Temporal transcriptional profiling of
somatic and germ cells reveals biased lineage priming of sexual fate in the fetal mouse gonad. PLoS Genet.
2012;8(3):e1002575.
17. Munger SC, Natarajan A, Looger LL, Ohler U, Capel B. Fine time course expression analysis identifies cascades of
activation and repression and maps a putative regulator of mammalian sex determination. PLoS Genet. 2013;9(7):
e1003630.
18. Hughes IA, Houk Ch, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. J Pediatr Urol.
2006;2(3):148–62.
19. Mendonca BB, Domenice S, Arnhold IJ, Costa EM. 46,XY disorders of sex development (DSD). Clin Endocrinol.
2009;70(2):173–87.
20. López M, Torres L, Méndez JP, Cervantes A, Perez-Palacios G, Erickson RP. Clinical traits and molecular finding in
46,XX males. Clin Genet. 1995;48(1):29–34.
21. Kousta E, Papathanasiou A, Skordis N. Sex determination and disorders of sex development according to the
revised nomenclature and classification in 46, XX individuals. Hormones (Athens). 2010;9(3):218–31.
22. Saadatpour A, Albert R. Boolean modeling of biological regulatory networks: a methodology tutorial. Methods.
2013;62(1):3–12.
23. Karlebach G, Shamir R. Modelling, analysis of gene regulatory networks. Nat Rev Mol Cell Bio. 2008;9(10):770–80.
24. Sanchez-Corrales YE, Alvarez-Buylla ER, Mendoza L. The Arabidopsis thaliana flower organ specification gene
regulatory network determines a robust differentiation process. J Theor Biol. 2010;264(3):971–83.
25. Herrmann F, Groß A, Zhou D, Kestler HA, Kühl M. A Boolean model of the cardiac gene regulatory network
determining first and second heart field identity. PLoS ONE. 2012;7(10):e46798.
26. Albert R, Othmer HG. The topology of the regulatory interactions predicts the expression pattern of the segment
polarity genes in Drosophila melanogaster. J Theor Biol. 2003;223(1):1–18.
27. Fleming A, Vilain E. The endless quest for sex determination genes. Clin genet. 2005;67(1):15–25.
28. Ono M, Harley VR. Disorders of sex development: new genes new concepts. Nat Rev Endocrinol. 2013;9(2):79–91.
29. McConnell MJ, Cunliffe HE, Chua LJ, Ward TA, Eccles MR. Differential regulation of the human Wilms tumour
suppressor gene (WT1) promoter by two isoforms of PAX2. Oncogene. 1997;14(22):2689–700.
30. Kobayashi A, Shawlot W, Kania A, Behringer RR. Requirement of Lim1 for female reproductive tract development.
Development. 2004;131(3):539–49.
31. Wilhelm D, Englert Ch. The Wilms tumor suppressor WT1 regulates early gonad development by activation of SF1.
Genes Dev. 2002;16(14):1839–51.
32. Manuylov NL, Smagulova FO, Leach L, Tevosian SG. Ovarian development in mice requires the GATA4-FOG2
transcription complex. Development. 2008;135(22):3731–43.
33. Müssel Ch, Hopfensitz M, Kestler HA. BoolNet an R package for generation reconstruction and analysis of Boolean
networks. Bioinformatics. 2010;26(10):1378–80.
34. Tomaselli S, Megiorni F, Lin L, Mazzilli MC, Gerrelli D, Majore S, et al. Human RSPO1/R-spondin1 is expressed
during early ovary development and augments β-catenin signaling. PLoS One. 2011;6(1):e16366.
35. Barbaro M, Oscarson M, Schoumans J, Staaf J, Ivarsson SA, Wedell A. Isolated 46, XY gonadal dysgenesis in two
sisters caused by a Xp21. 2 interstitial duplication containing the DAX1 gene. J Clin Endocrinol Metab. 2007;92(8):
3305–13.
36. Meeks JJ, Crawford SE, Russell TA, Morohashi K, Weiss J, Jameson JL. Dax1 regulates testis cord organization
during gonadal differentiation. Development. 2003;130(5):1029–36.
37. Ludbrook LM, Harley VR. Sex determination: a window of DAX1 activity. Trends Endocrin Met. 2004;15(3):116–21.
38. Hersmus R, Kalfa N, de Leeuw BHCGM, Stoop H, Oosterhuis JW, de Krijger R, et al. FOXL2 and SOX9 as parameters
of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). J
Pathol. 2008;215(1):31–8.
39. Maatouk DM, DiNapoli L, Alvers A, Parker KL, Taketo MM, Capel B. Stabilization of β-catenin in XY gonads causes
male-to-female sex-reversal. Hum Mol Genet. 2008;17(19):2949–55.
40. Alves C, Braid Z, Coeli FB, Mello MP. 46 XX Male-testicular disorder of sexual differentiation (DSD): hormonal
molecular and cytogenetic studies. Arq Bras Endocrinol. 2010;54(8):685–9.
41. Harley VR, Clarkson MJ, Argentaro A. The molecular action and regulation of the testis-determining factors SRY
(Sex-determining Region on the Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9]. Endocr
rev. 2003;24(4):466–87.
42. Hawkins JR, Taylor A, Goodfellow PN, Migeon CJ, Smith KD, Berkovitz GD. Evidence for increased prevalence of SRY
mutations in XY females with complete rather than partial gonadal dysgenesis. Am J Hum Genet. 1992;51(5):979.
43. Yueh-Chiang Hu, Okumura LM, Page DC. Gata4 is required for formation of the genital ridge in mice. PLoS Genet.
2013;9(7):e1003629.
44. Miyamoto Y, Taniguchi H, Hamel F, Silversides DW, Viger RS. A GATA4/WT1 cooperation regulates transcription of
genes required for mammalian sex determination and differentiation. BMC Mol Biol. 2008;9(1):44.
Ríos et al. Theoretical Biology andMedical Modelling  (2015) 12:26 Page 18 of 18
45. Tremblay JJ, Viger RS. A mutated form of Steroidogenic factor 1 (SF-1 G35E that causes sex reversal in humans fails
to synergize with transcription factor GATA-4. J Biol Chem. 2003;278(43):42637–42.
46. Lourenço D, Brauner R, Rybczyn´ska M, Nihoul-Fékété C, McElreavey K, Bashamboo A. Loss-of-function mutation in
GATA4 causes anomalies of human testicular development. Proc Natl Acad Sci U S A. 2011;108(4):1597–602.
47. Köhler B, Biebermann H, Friedsam V, Gellermann J, Maier RF, Pohl M, et al. Analysis of the Wilms’ tumor suppressor
gene (WT1) in patients 46, XY disorders of sex development. Clin Endocrinol Metab. 2011;96(7):E1131–6.
48. Kim J, Prawitt D, Bardeesy N, Torban E, Vicaner C, Goodyer P, et al. The Wilms’ tumor suppressor geneWT1
product regulates DAX-1 gene expression during gonadal differentiation. Mol Cellular Biol. 1999;19(3):2289–99.
49. Huang C-C, Orvis GD, Kwan KM, Behringer RR. Lhx1 is required in Müllerian duct epithelium for uterine
development. Dev Biol. 2014;389(2):124–36.
50. Fraizer GC, Shimamura R, Zhang X, Saunders GF. PAX8 regulates humanWT1 transcription through a novel DNA
binding site. J Biol Chem. 1997;272(49):30678–87.
51. Cadigan KM, Waterman ML. TCF/LEFs and Wnt signaling in the nucleus. Cold Spring Harbor Perspectives Biol.
2012;4(11):a007906.
52. Tevosian SG, Manuylov NL. To β or not to β Canonical β-catenin signaling pathway and ovarian development. Dev
Dynam. 2008;237(12):3672–80.
53. Mazen I, Hamid A, El-Gammal M, Aref A, Amr K. AMH gene mutations in two Egyptian families with persistent
Müllerian duct syndrome. Sex Dev. 2011;5(6):277–80.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
